These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Anemia of prematurity: the prospects for avoiding blood transfusions by treatment with recombinant human erythropoietin. Dallman PR. Adv Pediatr; 1993 Apr 28; 40():385-403. PubMed ID: 8249712 [No Abstract] [Full Text] [Related]
3. The effect of epoetin beta (recombinant human erythropoietin) on the need for transfusion in very-low-birth-weight infants. European Multicentre Erythropoietin Study Group. Maier RF, Obladen M, Scigalla P, Linderkamp O, Duc G, Hieronimi G, Halliday HL, Versmold HT, Moriette G, Jorch G. N Engl J Med; 1994 Apr 28; 330(17):1173-8. PubMed ID: 8139627 [Abstract] [Full Text] [Related]
4. Recombinant erythropoietin in anemia of prematurity: five years later. Shannon K. Pediatrics; 1993 Oct 28; 92(4):614-7. PubMed ID: 8414840 [No Abstract] [Full Text] [Related]
5. Use of epoetin (erythropoietin) in the anemia of prematurity. Novick D, Moore TB, Feig SA. West J Med; 1995 Apr 28; 162(4):355-6. PubMed ID: 7747503 [No Abstract] [Full Text] [Related]
6. Recombinant erythropoietic growth factors as an alternative to erythrocyte transfusion for patients with "anemia of prematurity". Christensen RD. Pediatrics; 1989 May 28; 83(5):793-6. PubMed ID: 2717299 [No Abstract] [Full Text] [Related]
7. Recombinant erythropoietin in very-low-birth-weight infants. Beck D, Calame A, Masserey E. N Engl J Med; 1994 Sep 08; 331(10):676-7; author reply 677-8. PubMed ID: 8052281 [No Abstract] [Full Text] [Related]
8. Recombinant erythropoietin in very-low-birth-weight infants. Carnielli VP, Da Riol R, Montini G. N Engl J Med; 1994 Sep 08; 331(10):677; author reply 677-8. PubMed ID: 8052282 [No Abstract] [Full Text] [Related]
15. [Therapeutic use of hematopoietic growth factors. I. Erythropoietin and thrombopoietin]. Royer B, Arock M. Ann Biol Clin (Paris); 1998 Sep 08; 56(2):143-52. PubMed ID: 9754239 [Abstract] [Full Text] [Related]
16. Recombinant human erythropoietin therapy in low-birthweight preterm infants: a prospective controlled study. Arif B, Ferhan K. Pediatr Int; 2005 Feb 08; 47(1):67-71. PubMed ID: 15693870 [Abstract] [Full Text] [Related]
17. A randomized, placebo-controlled clinical trial of recombinant human erythropoietin in the anemia of prematurity. Mentzer WC, Shannon KM, Abels RI, Freeman P, Newton N, Thompson D, Phibbs RH. Contrib Nephrol; 1991 Feb 08; 88():306-12; discussion 313. PubMed ID: 2040193 [No Abstract] [Full Text] [Related]
18. Erythropoietin--not yet a standard treatment for anemia of prematurity. Wilimas JA, Crist WM. Pediatrics; 1995 Jan 08; 95(1):9-10. PubMed ID: 7770317 [No Abstract] [Full Text] [Related]
19. Recombinant human erythropoietin in the treatment of the anemia of prematurity: results of a double-blind, placebo-controlled study. Meyer MP, Meyer JH, Commerford A, Hann FM, Sive AA, Moller G, Jacobs P, Malan AF. Pediatrics; 1994 Jun 08; 93(6 Pt 1):918-23. PubMed ID: 8190577 [Abstract] [Full Text] [Related]
20. Early treatment of premature infants with recombinant human erythropoietin. Messer J, Haddad J, Donato L, Astruc D, Matis J. Pediatrics; 1993 Oct 08; 92(4):519-23. PubMed ID: 8414820 [Abstract] [Full Text] [Related] Page: [Next] [New Search]